Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Oncoimmunology|May 7, 2014
Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapyYuting Ma, Sandy Adjemian, Lorenzo Galluzzi, et al.Human Vaccines & Immunotherapeutics|January 7, 2017
Near future of tumor immunology: Anticipating resistance mechanisms to immunotherapies, a big challenge for clinical trialsJoão Paulo Portela Catani, Rachel P Riechelmann, Sandy Adjemian, et al.Nature Communications|June 27, 2022
Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunityBartosz Wiernicki, Sophia Maschalidi, Jonathan Pinney, et al.Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Quantification of cell cycle-arresting proteinsOliver Kepp, Isabelle Martins, Laurie Menger, et al.Frontiers in Immunology|November 22, 2018
Pattern Recognition Receptors and the Host Cell Death Molecular MachineryGustavo P Amarante-Mendes, Sandy Adjemian, Laura Migliari Branco, et al.Methods in Molecular Biology (Clifton, N.J.)|June 5, 2013
Fluorescent biosensors for the detection of HMGB1 releaseIsabelle Martins, Oliver Kepp, Laurie Menger, et al.Cell Cycle (Georgetown, Tex.)|August 3, 2013
Antiapoptotic activity of argon and xenonSabrina Spaggiari, Oliver Kepp, Santiago Rello-Varona, et al.Frontiers in Oncology|July 29, 2022
Association of Cell Death Markers With Tumor Immune Cell Infiltrates After Chemo-Radiation in Cervical CancerTeodora Oltean, Lien Lippens, Kelly Lemeire, et al.Annals of the New York Academy of Sciences|October 21, 2010
Surface-exposed calreticulin in the interaction between dying cells and phagocytesIsabelle Martins, Oliver Kepp, Lorenzo Galluzzi, et al.Cell Cycle (Georgetown, Tex.)|November 11, 2009
Disruption of the PP1/GADD34 complex induces calreticulin exposureOliver Kepp, Lorenzo Galluzzi, Fabrizio Giordanetto, et al.Pageof 4